BAM
BIIB icon

Baldrige Asset Management’s Biogen BIIB Stock Holding History

Baldrige Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1K Buy
+2
New +$553 ﹤0.01% 334

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baldrige Asset Management's BIIB Position: Q1 2023 in Review

Baldrige Asset Management opened a new position in Biogen (BIIB) in Q1 2023: 2 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #334 among its holdings.

1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Baldrige Asset Management held 2 shares of Biogen worth $1K as of Q1 2023.
  • Biogen was a new Baldrige Asset Management position in Q1 2023.
  • Biogen made up ﹤0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #334 holding.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.